The clinical features and prognosis of type 4C myocardial infarction in patients with non-ST-segment elevation myocardial infarction.
Wang J, Gao H, Xiao J, Gao M, Liu Y, Gao J.
Ann Transl Med. 2021 Jul;9(14):1153. doi: 10.21037/atm-21-2587.
Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial.
Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, Hébert PC; MINT Investigators.
Am Heart J. 2023 Mar;257:120-129. doi: 10.1016/j.ahj.2022.11.015. Epub 2022 Nov 20.
[Clinical implications of the fourth universal definition of myocardial infarction].
Eckner D, Pauschinger M, Ademaj F, Martinovic K.
Herz. 2020 Sep;45(6):520-527. doi: 10.1007/s00059-020-04948-6.
Detection and evaluation of renal biomarkers in a swine model of acute myocardial infarction and reperfusion.
Duan SY, Xing CY, Zhang B, Chen Y.
Int J Clin Exp Pathol. 2015 Jul 1;8(7):8336-47. eCollection 2015.
Mechanical Prosthetic Aortic Valve Thrombosis Complicated by an Acute Coronary Syndrome During Fibrinolysis.
Aoun J, Assaker JP, Faza N, Kleiman NS, Zacca N, Little SH.
JACC Case Rep. 2020 Nov 4;2(14):2186-2190. doi: 10.1016/j.jaccas.2020.08.029. eCollection 2020 Nov 18.
Circulating concentrations of fibroblast activation protein alpha in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA.
Tillmanns J, Widera C, Habbaba Y, Galuppo P, Kempf T, Wollert KC, Bauersachs J.
Int J Cardiol. 2013 Oct 9;168(4):3926-31. doi: 10.1016/j.ijcard.2013.06.061. Epub 2013 Aug 6.
Distribution of KAI-9803, a novel δ-protein kinase C inhibitor, after intravenous administration to rats.
Miyaji Y, Walter S, Chen L, Kurihara A, Ishizuka T, Saito M, Kawai K, Okazaki O.
Drug Metab Dispos. 2011 Oct;39(10):1946-53. doi: 10.1124/dmd.111.040725. Epub 2011 Jun 28.
Verification of an immunoturbidimetric assay for heart-type fatty acid-binding protein (H-FABP) on a clinical chemistry platform and establishment of the upper reference limit.
Da Molin S, Cappellini F, Falbo R, Signorini S, Brambilla P.
Clin Biochem. 2014 Nov;47(16-17):247-9. doi: 10.1016/j.clinbiochem.2014.07.011. Epub 2014 Jul 18.
